GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hexima Ltd (ASX:HXL) » Definitions » Change In Payables And Accrued Expense

Hexima (ASX:HXL) Change In Payables And Accrued Expense : A$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Hexima Change In Payables And Accrued Expense?

Hexima's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was A$0.00 Mil. It means Hexima's Accounts Payable & Accrued Expense stayed the same from Jun. 2023 to Dec. 2023 .

Hexima's Change In Payables And Accrued Expense for the fiscal year that ended in Jun. 2023 was A$0.00 Mil. It means Hexima's Accounts Payable & Accrued Expense stayed the same from Jun. 2022 to Jun. 2023 .


Hexima Change In Payables And Accrued Expense Historical Data

The historical data trend for Hexima's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hexima Change In Payables And Accrued Expense Chart

Hexima Annual Data
Trend Jun08 Jun09 Jun10 Jun20 Jun21 Jun22 Jun23
Change In Payables And Accrued Expense
Get a 7-Day Free Trial - - - - -

Hexima Semi-Annual Data
Dec06 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Hexima Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hexima Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Hexima's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Hexima (ASX:HXL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hexima Ltd (ASX:HXL) » Definitions » Change In Payables And Accrued Expense
Traded in Other Exchanges
N/A
Address
84-90 Hotham Street, Corporate One, Preston, VIC, AUS, 3072
Hexima Ltd is a biotechnology company. The company is engaged in the research and development of plant-derived proteins and peptides for applications as human therapeutics.

Hexima (ASX:HXL) Headlines

From GuruFocus

Hexcel Declares Quarterly Dividend

By Business Wire Business Wire 01-26-2022

Hexcel Schedules Third Quarter 2021 Earnings Release and Conference Call

By Business Wire Business Wire 10-01-2021

Top 5 4th Quarter Trades of Bouvel Investment Partners, LLC

By GuruFocus Research GuruFocus Editor 01-19-2023

Hexcel Reports 2023 Second Quarter Results

By Business Wire 07-24-2023

Hexcel Declares Quarterly Dividend

By Business Wire Business Wire 01-25-2023

Hexcel Schedules First Quarter 2022 Earnings Release and Conference Call

By Business Wire Business Wire 04-01-2022

Hexcel Declares Quarterly Dividend

By Business Wire Business Wire 07-25-2022